Journal Article
P. Chatterjee, Elmi, M., Goozee, K., Shah, T., Sohrabi, H. R., Dias, C. B., Pedrini, S., Shen, K., Asih, P. R., Dave, P., Taddei, K., Vanderstichele, H., Zetterberg, H., Blennow, K., and Martins, R. N.,
“Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease.”,
J Alzheimers Dis, vol. 71, no. 3, pp. 775-783, 2019.
S. Salloway, Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., Reichert, M., Ketter, N., Nejadnik, B., Guenzler, V., Miloslavsky, M., Wang, D., Lu, Y., Lull, J., Tudor, I. Cristina, Liu, E., Grundman, M., Yuen, E., Black, R., and H Brashear, R.,
“Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.”,
N Engl J Med, vol. 370, no. 4, pp. 322-33, 2014.
H. Lukkarinen, Tesseur, I., Pemberton, D., van der Ark, P., Timmers, M., Slemmon, R., Janssens, L., Streffer, J., Van Nueten, L., Bottelbergs, A., Rauramaa, T., Koivisto, A. M., Herukka, S. - K., Korhonen, V. E., Junkkari, A., Hiltunen, M., Engelborghs, S., Blennow, K., Zetterberg, H., Kolb, H. C., and Leinonen, V.,
“Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.”,
J Alzheimers Dis, vol. 80, no. 4, pp. 1629-1642, 2021.
U. Smailovic, Kåreholt, I., Koenig, T., Ashton, N. J., Winblad, B., Höglund, K., Nilsson, P., Zetterberg, H., Blennow, K., and Jelic, V.,
“Synaptic Molecular and Neurophysiological Markers Are Independent Predictors of Progression in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 83, no. 1, pp. 355-366, 2021.
E. Portelius, Durieu, E., Bodin, M., Cam, M., Pannee, J., Leuxe, C., Mabondzo, A., Oumata, N., Galons, H., Lee, J. Yeol, Chang, Y. - T., Stϋber, K., Koch, P., Fontaine, G., Potier, M. - C., Manousopoulou, A., Garbis, S. D., Covaci, A., Van Dam, D., De Deyn, P., Karg, F., Flajolet, M., Omori, C., Hata, S., Suzuki, T., Blennow, K., Zetterberg, H., and Meijer, L.,
“Specific Triazine Herbicides Induce Amyloid-β42 Production.”,
J Alzheimers Dis, vol. 54, no. 4, pp. 1593-1605, 2016.
P. Chatterjee, Mohammadi, M., Goozee, K., Shah, T. M., Sohrabi, H. R., Dias, C. B., Shen, K., Asih, P. R., Dave, P., Pedrini, S., Ashton, N. J., Hye, A., Taddei, K., Lovejoy, D. B., Zetterberg, H., Blennow, K., and Martins, R. N.,
“Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load.”,
J Alzheimers Dis, vol. 76, no. 1, pp. 291-301, 2020.
V. Leinonen, Rauramaa, T., Johansson, J., Bottelbergs, A., Tesseur, I., van der Ark, P., Pemberton, D., Koivisto, A. M., Jääskeläinen, J. E., Hiltunen, M., Herukka, S. - K., Blennow, K., Zetterberg, H., Jokinen, P., Rokka, J., Helin, S., Haaparanta-Solin, M., Solin, O., Okamura, N., Kolb, H. C., and Rinne, J. O.,
“S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies.”,
J Alzheimers Dis, vol. 64, no. 1, pp. 171-179, 2018.
P. Johansson, Almqvist, E. G., Bjerke, M., Wallin, A., Johansson, J. - O., Andreasson, U., Blennow, K., Zetterberg, H., and Svensson, J.,
“Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.”,
J Alzheimers Dis, vol. 59, no. 3, pp. 1017-1026, 2017.
A. - V. Idland, Wyller, T. Bruun, Støen, R., Eri, L. Magne, Frihagen, F., Ræder, J., Chaudhry, F. Abbas, Hansson, O., Zetterberg, H., Blennow, K., Bogdanovic, N., Brækhus, A., and Watne, L. Otto,
“Preclinical Amyloid-β and Axonal Degeneration Pathology in Delirium.”,
J Alzheimers Dis, vol. 55, no. 1, pp. 371-379, 2017.
K. D. Deters, Risacher, S. L., Kim, S., Nho, K., West, J. D., Blennow, K., Zetterberg, H., Shaw, L. M., Trojanowski, J. Q., Weiner, M. W., and Saykin, A. J.,
“Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer's Disease.”,
J Alzheimers Dis, vol. 58, no. 4, pp. 1245-1254, 2017.
C. E. Teunissen, Chiu, M. - J., Yang, C. - C., Yang, S. - Y., Scheltens, P., Zetterberg, H., and Blennow, K.,
“Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 62, no. 4, pp. 1857-1863, 2018.
B. F. Darst, Koscik, R. L., Racine, A. M., Oh, J. M., Krause, R. A., Carlsson, C. M., Zetterberg, H., Blennow, K., Christian, B. T., Bendlin, B. B., Okonkwo, O. C., Hogan, K. J., Hermann, B. P., Sager, M. A., Asthana, S., Johnson, S. C., and Engelman, C. D.,
“Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-β Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease.”,
J Alzheimers Dis, vol. 55, no. 2, pp. 473-484, 2017.
P. Lewczuk, Lelental, N., Lachmann, I., Holzer, M., Flach, K., Brandner, S., Engelborghs, S., Teunissen, C. E., Zetterberg, H., Molinuevo, J. Luis, Mroczko, B., Blennow, K., Popp, J., Parnetti, L., Chiasserini, D., Perret-Liaudet, A., Spitzer, P., Maler, J. Manuel, and Kornhuber, J.,
“Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization.”,
J Alzheimers Dis, vol. 55, no. 1, pp. 159-170, 2017.
I. Skoog, Kern, S., Zetterberg, H., Östling, S., Börjesson-Hanson, A., Guo, X., and Blennow, K.,
“Low Cerebrospinal Fluid Aβ42 and Aβ40 are Related to White Matter Lesions in Cognitively Normal Elderly.”,
J Alzheimers Dis, vol. 62, no. 4, pp. 1877-1886, 2018.
S. E. Berman, Clark, L. R., Rivera-Rivera, L. A., Norton, D., Racine, A. M., Rowley, H. A., Bendlin, B. B., Blennow, K., Zetterberg, H., Carlsson, C. M., Asthana, S., Turski, P., Wieben, O., and Johnson, S. C.,
“Intracranial Arterial 4D Flow in Individuals with Mild Cognitive Impairment is Associated with Cognitive Performance and Amyloid Positivity.”,
J Alzheimers Dis, vol. 60, no. 1, pp. 243-252, 2017.
S. M. Hoscheidt, Starks, E. J., Oh, J. M., Zetterberg, H., Blennow, K., Krause, R. A., Gleason, C. E., Puglielli, L., Atwood, C. S., Carlsson, C. M., Asthana, S., Johnson, S. C., and Bendlin, B. B.,
“Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults.”,
J Alzheimers Dis, vol. 52, no. 4, pp. 1373-83, 2016.
R. Sala-Llonch, Idland, A. - V., Borza, T., Watne, L. Otto, Wyller, T. Bruun, Brækhus, A., Zetterberg, H., Blennow, K., Walhovd, K. Beate, and Fjell, A. Martin,
“Inflammation, Amyloid, and Atrophy in The Aging Brain: Relationships with Longitudinal Changes in Cognition.”,
J Alzheimers Dis, vol. 58, no. 3, pp. 829-840, 2017.
M. Cam, Durieu, E., Bodin, M., Manousopoulou, A., Koslowski, S., Vasylieva, N., Barnych, B., Hammock, B. D., Bohl, B., Koch, P., Omori, C., Yamamoto, K., Hata, S., Suzuki, T., Karg, F., Gizzi, P., Haber, V. Erakovic, Mihaljevic, V. Bencetic, Tavcar, B., Portelius, E., Pannee, J., Blennow, K., Zetterberg, H., Garbis, S. D., Auvray, P., Gerber, H., Fraering, J., Fraering, P. C., and Meijer, L.,
“Induction of Amyloid-β42 Production by Fipronil and Other Pyrazole Insecticides.”,
J Alzheimers Dis, vol. 62, no. 4, pp. 1663-1681, 2018.
L. J. C. van Wa van Doorn, Gispert, J. D., H Kuiperij, B., Claassen, J. A. H. R., Arighi, A., Baldeiras, I., Blennow, K., Bozzali, M., Castelo-Branco, M., Cavedo, E., Emek-Savaş, D. D., Eren, E., Eusebi, P., Farotti, L., Fenoglio, C., Ormaechea, J. Fortea, Freund-Levi, Y., Frisoni, G. B., Galimberti, D., Genc, S., Greco, V., Hampel, H., Herukka, S. - K., Liu, Y., Lladó, A., Lleo, A., Nobili, F. M., Oguz, K. K., Parnetti, L., Pereira, J., Picco, A., Pikkarainen, M., de Oliveira, C. Resende, Saka, E., Salvadori, N., Sánchez-Valle, R., Santana, I., Scarpini, E., Scheltens, P., Soininen, H., Tarducci, R., Teunissen, C., Tsolaki, M., Urbani, A., Vilaplana, E., Visser, P. Jelle, Wallin, A. K., Yener, G., Molinuevo, J. L., Meulenbroek, O., and Verbeek, M. M.,
“Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes.”,
J Alzheimers Dis, vol. 56, no. 2, pp. 543-555, 2017.
J. Spiegel, Pirraglia, E., Osorio, R. S., Glodzik, L., Li, Y., Tsui, W., Louis, L. A. Saint, Randall, C., Butler, T., Xu, J., Zinkowski, R. P., Zetterberg, H., Fortea, J., Fossati, S., Wisniewski, T., Davies, P., Blennow, K., and de Leon, M. J.,
“Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease.”,
J Alzheimers Dis, vol. 49, no. 1, pp. 93-100, 2016.
C. - H. Andersson, Hansson, O., Minthon, L., Andreasen, N., Blennow, K., Zetterberg, H., Skoog, I., Wallin, A., Nilsson, S., and Kettunen, P.,
“A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer's Disease.”,
J Alzheimers Dis, vol. 53, no. 4, pp. 1353-63, 2016.
M. Carmona-Iragui, Santos, T., Videla, S., Fernández, S., Benejam, B., Videla, L., Alcolea, D., Blennow, K., Blesa, R., Lleo, A., and Fortea, J.,
“Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Subjects with Down Syndrome.”,
J Alzheimers Dis, vol. 55, no. 4, pp. 1489-1496, 2017.
A. Brugulat-Serrat, Cañas, A., Canals, L., Marne, P., Gramunt, N., Milà-Alomà, M., Suárez-Calvet, M., Arenaza-Urquijo, E. M., Grau-Rivera, O., González-de-Echávarri, J. María, Minguillon, C., Fauria, K., Kollmorgen, G., Suridjan, I., Zetterberg, H., Blennow, K., Gispert, J. Domingo, Molinuevo, J. Luis, and Sánchez-Benavides, G.,
“Enhancing the Sensitivity of Memory Tests: Reference Data for the Free and Cued Selective Reminding Test and the Logical Memory Task from Cognitively Healthy Subjects with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels.”,
J Alzheimers Dis, vol. 84, no. 1, pp. 119-128, 2021.
] 